Navigation Links
Helix BioPharma Chairman resigns
Date:10/15/2007

rmation as a result of numerous factors, including without limitation, Helix's need for additional capital in the near term and in future, which may not be available on acceptable terms or at all; and uncertainty whether Topical Interferon Alpha-2b, L-DOS47, or any other product will be developed and marketed successfully as a drug or at all. See a description of other risks and uncertainties affecting Helix and its business, as contained in Helix's latest Annual Information Form and other filings with the Canadian Securities Regulatory Authorities at http://www.sedar.com, any of which could cause actual results to vary materially from current results or Helix's anticipated future results. Forward-looking statements and information are based on the beliefs, opinions and expectations of Helix's management at the time they are made, and Helix does not assume any obligation, except as required by law, to update any forward-looking statement or information should those beliefs, opinions or expectations, or other circumstances change.


'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Kyron appoints former AMA chairman to board
2. Third Wave appoints new chairman
3. Cisco Chairman donates $31 million for UW building renovation
4. Bone Care Names New Chairman
5. Cisco Chairman Praises University Research
6. JT Packard exec resigns after settling copyright disputes
7. Donley resigns as WiCell director
8. Renaissance Learning CEO resigns to start company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Diagnostics Inc. (TSX:V: SQD), a life sciences company that ... advanced microarray diagnostics, today announced it has appointed ... team. In his capacity as CFO he will ... development stage to a commercially successful company including ... market strategy and to secure funding to drive ...
(Date:3/3/2015)... N.J. , March 3, 2015  Regenicin, Inc. ... company specializing in the development of and commercialization of ... tissues and organs, announced today that it has received ... with Amarantus Bioscience Holdings, Inc. (OTC Bulletin Board: ... the Agreement, Amarantus made the final payments due to ...
(Date:3/3/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or ... Expert Opinion on Biological Therapy , Dr. Michael ... , at the Henry Ford Hospital in ... (TB4) has the capacity to promote CNS and peripheral ... leading to neurological recovery in each case.  They pointed ...
(Date:3/3/2015)... March 3, 2015 Kindred Biosciences, Inc. (NASDAQ: ... improving the lives of pets, announced today that it will ... March 12, 2015 after the market close. The Company will ... day. Interested parties may access the call ... 756-4262 internationally, and using conference ID 98449349.  ...
Breaking Biology Technology:SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
... Nov. 16, 2010 Reportlinker.com announces that a ... catalogue: Global Specialty Enzymes Industry ... This report analyzes the worldwide markets for Specialty ... segments - Specialty Medical Enzymes, Polymerases, Nucleases, and ...
... by researchers from Imperial College London, involves a new ... engineered to distort light or sound waves. With conventional ... with metamaterials, scientists can exploit a wealth of additional ... parts of the electromagnetic spectrum, an image can be ...
... 2010 Palatin Technologies, Inc. (NYSE Amex: PTN ... mimetic and small molecule agonist compounds with a focus on ... its first quarter ended September 30, 2010. Palatin reported a ... diluted share, for the quarter ended September 30, 2010, compared ...
Cached Biology Technology:Reportlinker Adds Global Specialty Enzymes Industry 2Reportlinker Adds Global Specialty Enzymes Industry 3Reportlinker Adds Global Specialty Enzymes Industry 4Reportlinker Adds Global Specialty Enzymes Industry 5Reportlinker Adds Global Specialty Enzymes Industry 6Reportlinker Adds Global Specialty Enzymes Industry 7Reportlinker Adds Global Specialty Enzymes Industry 8Reportlinker Adds Global Specialty Enzymes Industry 9Reportlinker Adds Global Specialty Enzymes Industry 10Reportlinker Adds Global Specialty Enzymes Industry 11Reportlinker Adds Global Specialty Enzymes Industry 12Reportlinker Adds Global Specialty Enzymes Industry 13Reportlinker Adds Global Specialty Enzymes Industry 14Reportlinker Adds Global Specialty Enzymes Industry 15Reportlinker Adds Global Specialty Enzymes Industry 16Reportlinker Adds Global Specialty Enzymes Industry 17Reportlinker Adds Global Specialty Enzymes Industry 18Reportlinker Adds Global Specialty Enzymes Industry 19Reportlinker Adds Global Specialty Enzymes Industry 20Reportlinker Adds Global Specialty Enzymes Industry 21Reportlinker Adds Global Specialty Enzymes Industry 22Reportlinker Adds Global Specialty Enzymes Industry 23Reportlinker Adds Global Specialty Enzymes Industry 24'Space-time cloak' to conceal events revealed in new study 2'Space-time cloak' to conceal events revealed in new study 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010 2Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010 4
(Date:2/5/2015)... Jan. 30, 2015  It is gratifying to see ... potential for genomic science as a means to better ... and treatment.  I was honored to participate in today,s ... medicine program. Since the 1980s my ... genomics—from the first sequenced genome of a free living ...
(Date:1/22/2015)... 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is ... the State of Washington,s Department of ... enrollment and central issuance system for driver,s licenses and identification ... project planning and development will start in January 2015, with ...
(Date:1/22/2015)... Jan. 13, 2015 Technology Showcase, Hall E -   ... solutions, today announced it will showcase its EyeLock ID technology ... the Department of Energy,s Oak Ridge National Laboratory ... . EyeLock,s iris identity authentication technology is being used to ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Valid USA Signs Contract For Washington Driver's License Issuance 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... dramatically better computer tool for finding the genetic missteps ... Children,s Research Hospital Washington University Pediatric Cancer Genome ... help identify the chromosomal rearrangements and DNA insertions or ... is known as CREST, short for Clipping Reveals Structure. ...
... announces that a new market research report is available ... Microarrays and Lab-on-a-Chip http://www.reportlinker.com/p0170497/Global-Biochip-Markets-Microarrays-and-Lab-on-a-Chip.html ... STUDY GOALS AND OBJECTIVES BCC,s goal ... current and emerging biochip technologies and products, and assess ...
... An outbreak of Escherichia coli causing a severe illness ... 2011 and has killed more than 20 people and sickened ... identified as a strain of E. coli O104:H4 ... to infection with E. coli O157:H7. Two isolates ...
Cached Biology News:Researchers improve method for finding genetic mistakes that fuel cancer 2Researchers improve method for finding genetic mistakes that fuel cancer 3Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 2Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 3Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 4Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 5Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 6Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 7Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 8Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 9Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 10Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 11Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 12Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 13Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 14Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip 15Two isolates from E. coli outbreak available 2
... We deliversoluble protein or No Charge to ... best soluble protein results , 24 solubility ... , Powerful results on your most insoluble ... Service (SOS) uses proprietary tools and know-how ...
... scale kinase profiling, quantitative measurement of ... research built on the flexible and ... These microarrays are available as part ... - Peptide Microarray Service. ...
... Microarrays designed for immunological studies, ... on the flexible and powerful Paraflo ... are available as part of our ... Custom Probe Content Probe ...
... Molecular Imaging (MI) Software for use in ... and drug discovery applications. The Regulatory Edition ... Drug Administrations Code of Federal Regulations Title ... [21 CFR Part 11]. KODAK MI Software, ...
Biology Products: